185 related articles for article (PubMed ID: 34306165)
1. Determining the Traditional Chinese Medicine (TCM) Syndrome with the Best Prognosis of HBV-Related HCC and Exploring the Related Mechanism Using Network Pharmacology.
Wu Z; Wei C; Wang L; He L
Evid Based Complement Alternat Med; 2021; 2021():9991533. PubMed ID: 34306165
[TBL] [Abstract][Full Text] [Related]
2. A systematic study on the treatment of hepatitis B-related hepatocellular carcinoma with drugs based on bioinformatics and key target reverse network pharmacology and experimental verification.
Li S; Hao L; Hu X; Li L
Infect Agent Cancer; 2023 Jul; 18(1):41. PubMed ID: 37393234
[TBL] [Abstract][Full Text] [Related]
3. A systematic study of traditional Chinese medicine treating hepatitis B virus-related hepatocellular carcinoma based on target-driven reverse network pharmacology.
Yin X; Li J; Hao Z; Ding R; Qiao Y
Front Cell Infect Microbiol; 2022; 12():964469. PubMed ID: 36046748
[TBL] [Abstract][Full Text] [Related]
4. Systematic Elucidation of the Potential Mechanisms of Core Chinese Materia Medicas in Treating Liver Cancer Based on Network Pharmacology.
Wu Z; Yang L; He L; Wang L; Peng L
Evid Based Complement Alternat Med; 2020; 2020():4763675. PubMed ID: 32382293
[TBL] [Abstract][Full Text] [Related]
5. Exploring the effect of Gupi Xiaoji Prescription on hepatitis B virus-related liver cancer through network pharmacology and in vitro experiments.
Yu S; Gao W; Zeng P; Chen C; Zhang Z; Liu Z; Liu J
Biomed Pharmacother; 2021 Jul; 139():111612. PubMed ID: 33915505
[TBL] [Abstract][Full Text] [Related]
6. [Investigation on traditional Chinese medicine syndrome distribution of 4 618 hepatitis B virus infection subjects in Qidong of Jiangsu Province, China].
Lang QB; Zhai DX; Huang F; Chen JG; Zhang YH; Liu Q; Zhai XF; Li B; Ling CQ
Zhong Xi Yi Jie He Xue Bao; 2012 May; 10(5):525-31. PubMed ID: 22587974
[TBL] [Abstract][Full Text] [Related]
7. Circulating Cell-Free mtDNA Content as a Non-invasive Prognostic Biomarker in HCC Patients Receiving TACE and Traditional Chinese Medicine.
Zhou G; Li Y; Li S; Liu H; Xu F; Lai X; Zhang Q; Xu J; Wan S
Front Genet; 2021; 12():719451. PubMed ID: 34603382
[TBL] [Abstract][Full Text] [Related]
8. Effects of adjuvant traditional Chinese medicine therapy on long-term survival in patients with hepatocellular carcinoma.
Liu X; Li M; Wang X; Dang Z; Yu L; Wang X; Jiang Y; Yang Z
Phytomedicine; 2019 Sep; 62():152930. PubMed ID: 31128485
[TBL] [Abstract][Full Text] [Related]
9. Study on the anti-tumor mechanism related to immune microenvironment of Bombyx Batryticatus on viral and non-viral infections of hepatocellular carcinoma.
Yuan L; Bing Z; Han J; An X; Liu X; Li R; Wang C; Sun X; Yang L; Yang K
Biomed Pharmacother; 2020 Apr; 124():109838. PubMed ID: 31981943
[TBL] [Abstract][Full Text] [Related]
10. Systematically Exploring the Antitumor Mechanisms of Core Chinese Herbs on Hepatocellular Carcinoma: A Computational Study.
Wu Z; He L; Wang L; Peng L
Evid Based Complement Alternat Med; 2020; 2020():2396569. PubMed ID: 33014099
[TBL] [Abstract][Full Text] [Related]
11. Network Pharmacology and Pharmacological Evaluation Reveals the Mechanism of the
Jiang N; Li H; Sun Y; Zeng J; Yang F; Kantawong F; Wu J
Front Pharmacol; 2021; 12():618522. PubMed ID: 33746755
[No Abstract] [Full Text] [Related]
12. Molecular targets of Chinese herbs: a clinical study of hepatoma based on network pharmacology.
Gao L; Wang XD; Niu YY; Duan DD; Yang X; Hao J; Zhu CH; Chen D; Wang KX; Qin XM; Wu XZ
Sci Rep; 2016 May; 6():24944. PubMed ID: 27143508
[TBL] [Abstract][Full Text] [Related]
13. Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis.
Yang HI; Tseng TC; Liu J; Lee MH; Liu CJ; Su TH; Batrla-Utermann R; Chan HL; Kao JH; Chen CJ
Clin Gastroenterol Hepatol; 2016 Mar; 14(3):461-468.e2. PubMed ID: 26598229
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of immune function, hemorheological alterations and prognosis in colorectal cancer patients with different traditional Chinese medicine syndromes.
Wang CY; Ding HZ; Tang X; Li ZG
Cancer Biomark; 2018 Feb; 21(3):701-710. PubMed ID: 29171989
[TBL] [Abstract][Full Text] [Related]
15. Revealing the potential mechanism of Astragalus membranaceus improving prognosis of hepatocellular carcinoma by combining transcriptomics and network pharmacology.
Liu Z; Ma H; Lai Z
BMC Complement Med Ther; 2021 Oct; 21(1):263. PubMed ID: 34663301
[TBL] [Abstract][Full Text] [Related]
16. Integrating Network Pharmacology and Pharmacological Evaluation for Deciphering the Action Mechanism of Herbal Formula Zuojin Pill in Suppressing Hepatocellular Carcinoma.
Guo W; Huang J; Wang N; Tan HY; Cheung F; Chen F; Feng Y
Front Pharmacol; 2019; 10():1185. PubMed ID: 31649545
[TBL] [Abstract][Full Text] [Related]
17. Single-nodule hepatitis B virus-associated hepatocellular carcinoma smaller than 3 cm: two phenotypes defined by cluster analysis and their association with the outcome of ablation as the first-line therapy.
Chen S; Wu Y; Qi H; Shen L; Ma W; Cao F; Diao Y; Wang T; Ou S; Fan W
Int J Hyperthermia; 2021; 38(1):120-129. PubMed ID: 33541160
[TBL] [Abstract][Full Text] [Related]
18. Traditional Chinese medicine as supportive care for the management of liver cancer: Past, present, and future.
Liao X; Bu Y; Jia Q
Genes Dis; 2020 Sep; 7(3):370-379. PubMed ID: 32884991
[TBL] [Abstract][Full Text] [Related]
19. Correlation of Long Noncoding RNA SEMA6A-AS1 Expression with Clinical Outcome in HBV-Related Hepatocellular Carcinoma.
Yu S; Li N; Wang J; Fu Y; Huang Y; Yi P; Chen R; Tang D; Hu X; Fan X
Clin Ther; 2020 Mar; 42(3):439-447. PubMed ID: 32070484
[TBL] [Abstract][Full Text] [Related]
20. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
